CAV1 and early-onset autosomal dominant Alzheimer disease: Caveolin-1 may play a role in non-genomic steroid receptor mediated effects [31], [32] and has been implicated in several types of cancer, metabolic, and cardiovascular disease, and via its link with cholesterol transport in Alzheimer's disease [33].